Evidence map›Paper›PMID 29180821›Full record

ArticleScientific reports2017

Specific Features of SVZ Neurogenesis After Cortical Ischemia: a Longitudinal Study.

S Palma-Tortosa, A García-Culebras, A Moraga, O Hurtado, A Perez-Ruiz, V Durán-Laforet, J de la Parra, M I Cuartero, J M Pradillo, M A Moro and 1 more

Abstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed.

  1. Chronic treatment with adenosine A1 receptor antagonist promotes neurogenesis and improves outcome after cerebral ischemia.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2025
    Article
  2. Article
  3. International journal of molecular sciences · 2024
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. A Tale of Two: When Neural Stem Cells Encounter Hypoxia.Cellular and molecular neurobiology · 2023
    Review
  10. Article
  11. A transient magnetic resonance spectroscopy peri-ischemic peak: a possible radiological biomarker of post-stroke neurogenesis.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2023
    Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Post-stroke Neurogenesis: Friend or Foe?Frontiers in cell and developmental biology · 2021
    Review
  18. Inhibition of LPABiomolecules & therapeutics · 2020
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

S Palma-TortosaUnidad de Investigación Neurovascular, Departamento de Farmacología and Instituto Universitario de Investigación en Neuroquímica, Facultad de Medicina, Universidad Complutense; Instituto de Investigación Hospital 12 Octubre (i+12), Madrid, Spain.
A García-CulebrasUnidad de Investigación Neurovascular, Departamento de Farmacología and Instituto Universitario de Investigación en Neuroquímica, Facultad de Medicina, Universidad Complutense; Instituto de Investigación Hospital 12 Octubre (i+12), Madrid, Spain.
A MoragaUnidad de Investigación Neurovascular, Departamento de Farmacología and Instituto Universitario de Investigación en Neuroquímica, Facultad de Medicina, Universidad Complutense; Instituto de Investigación Hospital 12 Octubre (i+12), Madrid, Spain.
O HurtadoUnidad de Investigación Neurovascular, Departamento de Farmacología and Instituto Universitario de Investigación en Neuroquímica, Facultad de Medicina, Universidad Complutense; Instituto de Investigación Hospital 12 Octubre (i+12), Madrid, Spain.
A Perez-RuizUnidad de Investigación Neurovascular, Departamento de Farmacología and Instituto Universitario de Investigación en Neuroquímica, Facultad de Medicina, Universidad Complutense; Instituto de Investigación Hospital 12 Octubre (i+12), Madrid, Spain.
V Durán-LaforetUnidad de Investigación Neurovascular, Departamento de Farmacología and Instituto Universitario de Investigación en Neuroquímica, Facultad de Medicina, Universidad Complutense; Instituto de Investigación Hospital 12 Octubre (i+12), Madrid, Spain.
J de la ParraUnidad de Investigación Neurovascular, Departamento de Farmacología and Instituto Universitario de Investigación en Neuroquímica, Facultad de Medicina, Universidad Complutense; Instituto de Investigación Hospital 12 Octubre (i+12), Madrid, Spain.
M I CuarteroUnidad de Investigación Neurovascular, Departamento de Farmacología and Instituto Universitario de Investigación en Neuroquímica, Facultad de Medicina, Universidad Complutense; Instituto de Investigación Hospital 12 Octubre (i+12), Madrid, Spain.
J M PradilloUnidad de Investigación Neurovascular, Departamento de Farmacología and Instituto Universitario de Investigación en Neuroquímica, Facultad de Medicina, Universidad Complutense; Instituto de Investigación Hospital 12 Octubre (i+12), Madrid, Spain. jmpradil@ucm.es.ORCID 0000-0002-8266-7946
M A MoroUnidad de Investigación Neurovascular, Departamento de Farmacología and Instituto Universitario de Investigación en Neuroquímica, Facultad de Medicina, Universidad Complutense; Instituto de Investigación Hospital 12 Octubre (i+12), Madrid, Spain.
I LizasoainUnidad de Investigación Neurovascular, Departamento de Farmacología and Instituto Universitario de Investigación en Neuroquímica, Facultad de Medicina, Universidad Complutense; Instituto de Investigación Hospital 12 Octubre (i+12), Madrid, Spain. ignacio.lizasoain@med.ucm.es.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Stroke is a devastating disease with an increasing prevalence. Part of the current development in stroke therapy is focused in the chronic phase, where neurorepair mechanisms such as neurogenesis, are involved. In the adult brain, one of the regions where neurogenesis takes place is the subventricular zone (SVZ) of the lateral ventricles. Given the possibility to develop pharmacological therapies to stimulate this process, we have performed a longitudinal analysis of neurogenesis in a model of cortical ischemia in mice. Our results show an initial decrease of SVZ proliferation at 24 h, followed by a recovery leading to an increase at 14d and a second decrease 28d after stroke. Coinciding with the 24 h proliferation decrease, an increase in the eutopic neuroblast migration towards the olfactory bulb was observed. The analysis of the neuroblast ectopic migration from the SVZ toward the lesion showed an increase in this process from day 14 after the insult. Finally, our data revealed an increased number of new cortical neurons in the peri-infarct cortex 65d after the insult. In summary, we report here critical check-points about post-stroke neurogenesis after cortical infarcts, important for the pharmacological modulation of this process in stroke patients.

Indexed as

NeurogenesisAnimalsBiomarkersBrain InfarctionBrain IschemiaCell MovementDisease Models, AnimalFluorescent Antibody TechniqueLateral VentriclesLongitudinal StudiesMagnetic Resonance ImagingMaleMiceMicroscopy, ConfocalNeuronsBiomarkers

Identifiers

PMID29180821
PMCPMC5703956

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.